Homeopathy for Overweight and Obesity in Mexican Adolescents

• Status: Active, not recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy of a multidisciplinary intervention (diet, exercise, motivational support and homeopathy or placebo) for overweight and obesity in Mexican adolescents. Half of study participants will receive the multidisciplinary intervention plus Calcarea carbonica ostrearum, a homeopathic medicine, while the other half will receive the same multidisciplinary intervention plus placebo.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Juarez de Mexico
• Treatments: Calcium Carbonate

Criteria

Inclusion Criteria:

• 12 to 19 years old.

• At least elementary school.

• Overweight (BMI ≥ 85th but <95th percentile based on the Centers for Disease Control and Prevention growth chart) or obese (BMI ≥95th percentile).

• Fasting serum glucose <126 mg/dl.

• Glycosylated hemoglobin <6.5%.

• With symptoms that match with Calcarea carbonica ostrearum.

• Willingness to participate, and verbal and written consent.

Exclusion Criteria:

• Pregnancy or breastfeeding.

• Cases already undergoing treatment (homeopathic, nutritional or structured physical activity) for obesity within last three months.

• Currently use of metformin, orlistat, insulin, other antidiabetic medication, contraceptive pills, medications with effects on lipid metabolism [thiazide and loop diuretics, β and α receptor blockers, antiepileptic drugs (carbamazepine, phenytoin, valproic acid, phenobarbital), antipsychotics (clozapine), protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir, saquinavir), tamoxifen, raloxifene, isotretinoin, acitretin, ciclosporin, azathioprine, sirolimus].

• Any condition that prevents physical exercise.

• Diabetes, hypertension, thyroid diseases, Down syndrome, mental retardation.